Skip to main content
SP5007,785.76-0.17%DOW53,732.41-0.20%NASDAQ26,729.16-0.28%BTC$62,945.00-0.85%ETH$1,880.32-0.35%GOLD$4,432.00+0.26%OIL$82.40+1.42%
Smart Investors Daily
Sign InSign Up Free
PA

NASDAQ · PAYA

Paya Holdings Inc.

Technology · Software - Infrastructure

$9.74

Up+$0.00 (+0.00%)

Updated Aug 15, 2026, 1:01 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.29B
P/E ratio
149.62
Dividend yield
0.00%
52-week range
— – —
Volume
1.13M
Avg. volume
2.57M

Price performance

PAYA price history

1M range · 0 trading sessions · Daily adjusted prices

PAYA does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest PAYA news

The latest Smart Investors Daily articles mentioning PAYA.

Stock researchCompany · Overview

PAYA research

Overview

Company profile and research snapshot.

Company profile

Paya Holdings Inc., through its subsidiaries, operates as an independent integrated payments platform. It operates through two segments, Integrated Solutions and Payment Services. The company processes payments through credit and debit card, automated clearing house, and check payments. It serves customers through distribution partners with focus on targeted verticals, such as B2B goods and services, healthcare, faith-based and non-profit, government and utilities, and education markets. The company is headquartered in Atlanta, Georgia with additional offices in Reston, Virginia; Fort Walton Beach, Florida; Dayton, Ohio; Mt. Vernon, Ohio; Dallas, Texas; and Tempe, Arizona.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$9.21
Implied upside
—
Analysts
—
PAYA recent ratings
DateFirmRatingTarget
Jan 18, 2023DA DavidsonNeutral—
Jan 10, 2023BTIGNeutral—
Jan 10, 2023Credit SuisseNeutral—
Jan 10, 2023Morgan StanleyEqual-Weight—
Jan 10, 2023Raymond JamesMarket Perform—
Open full forecast

News briefing

No generated briefing is available yet.

globenewswire.com · Nov 20, 2025

IMU Biosciences Appoints Dr. Carlos Paya as Non-Executive Director, Strengthening its Board of Directors

PRESS RELEASE London, UK, 20 November 2025 — IMU Biosciences (or “the Company”), a biotechnology company decoding the immune system to drive next generation health outcomes, today announced the appointment of Dr. Carlos Paya as Non-Executive Director. Carlos has a distinguished track record of leadership spanning academic medicine and the biopharmaceutical industry, with deep expertise in drug development and commercial strategy across early-stage start-ups to large-cap pharmaceutical companies.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By